ABSTRACT
Fundamentos: Elevadas concentrações de homocisteína plasmática (Hcyp) têm sido associadas ao risco aumentado de doenças cardiovasculares. A Hcyp pode ser diminuída por meio da remetilação à metionina, que usa folato ou betaína como doador do grupo metil.Objetivos: Avaliar a ingestão de betaína e colina e sua relação com a homocisteína em residentes do município de São Paulo. Métodos: Obtidos dados de 584 indivíduos, de ambos os sexos, a partir do estudo de base populacional ISA-SP 2008. Médias geométricas de Hcyp foram analisadas de acordo com tercis de ingestão de colina e betaína e foi aplicado teste de tendência.Resultados: Foram analisados 584 indivíduos: 222 (38,0%) homens e 362 (62,0%) mulheres, com média de idade 55,0±19,0 anos. A prevalência de hiper-homocisteinemia foi maior entre os homens (28,0%), idosos (21,0%) e indivíduos com menor renda familiar (21,0%). Cerca de 31,0% dos indivíduos com hiper-homocisteinemia apresentou deficiência de folato (<7,5 nmol/L) e 26,0%, deficiência de vitamina B12 (<200 pmol/L). Observou-se diminuição nas médias geométricas de homocisteína conforme aumento nos tercis de betaína em ambos os sexos,adultos, eutróficos e em todas as categorias de escolaridade. A colina esteve relacionada à Hcyp em ambos os sexos, indivíduos de maior renda familiar, não fumantes e consumidores de bebidas alcoólicas. Conclusões: Este estudo sugere a importância da ingestão de betaína por sua associação inversa com a concentração de Hcyp em adultos e idosos do município de São Paulo. A colina desempenhou papel protetor em subgrupos específicos da população.
Background: High concentrations of plasma homocysteine (Hcyp) have been associated with increased risk of cardiovascular diseases. Hcyp can be decreased by remethylation to methionine, which uses folate or betaine as a donor of the methyl group. Objectives: To evaluate the intake of betaine and choline and its relation to homocysteine in residents of the city of São Paulo. Methods: Data from 584 individual, of both sexes, from the population-based study ISA-SP 2008. Geometric averages of Hcyp were analyzed according to choline and betaine intake tertiles and trend test was applied. Results: The study analyzed 584 individuals: 222 (38.0%) men and 362 (62.0%) women, mean age 55.0 ± 19.0 years. The prevalence of hyperhomocysteinemia was higher among men (28.0%), the elderly (21.0%) and those with lower household income (21.0%). Approximately 31.0% of individual with hyperhomocysteinemia presented folate deficiency (<7.5 nmol/L) and 26.0% presented vitamin B12 deficiency (<200 pmol/L). There was a decrease in the geometric means of homocysteine according to an increase in betaine tertiles in both sexes, adults, normal and in all categories of education. Choline was related to Hcyp in both sexes, higherhousehold income individuals, non-smokers and alcohol consumers. Conclusions: This study suggests the importance of betaine intake due to its inverse relationship with the concentration of Hcyp in adults and elderly in the city of São Paulo. Choline played a protective role in specific subgroups of the population.
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Adult , Aged , Brazil , Betaine/therapeutic use , Choline/therapeutic use , Diet , Homocysteine/adverse effects , Cross-Sectional Studies , /complications , Cardiovascular Diseases/epidemiology , Hyperhomocysteinemia , PrevalenceABSTRACT
The present study was conducted to compare choline with a placebo for its dose-effect relationship in management of bronchial asthma. Three groups: Group A: taking placebo (sorbitol), Group B: low dose choline (500 mg TDS), and Group C: high dose choline (1000 mg TDS) were assessed after a trial of four months. A decrease in symptoms score and increase in percent asymptomatic days was observed in all the three groups but was statistically significant only in the groups taking choline (Group B and C). Further, it was more significant in the group taking higher dose of choline (Group C). Average drug-requirement decreased in all the three groups but was significant only in the high dose choline group (Group C) Specific airway conductance (SGaw) at FRC and RV improved significantly only in group taking higher dose of choline (Group C), while no significant change in percent fall in SGaw at RV was observed in any group. It is, thus, concluded that choline is a useful prophylactic drug in the management of bronchial asthma. The improvement was more significant at a higher dose. Further studies are required to establish optimal dose of choline in the management of bronchial asthma.
Subject(s)
Adolescent , Adult , Asthma/drug therapy , Choline/therapeutic use , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Lysophosphatidylcholines/antagonists & inhibitors , Male , Respiratory Function Tests , Treatment OutcomeABSTRACT
The present study was conducted to compare the effects of disodium cromoglycate (DSCG) and choline, a lipotropic factor, in management of bronchial asthma. Two groups taking DSCG and choline were compared between themselves and with a control group (on bronchodilators only) in a three month trial. A significant improvement in average symptoms scores was observed in all groups but was clinically significant only in the groups taking choline. Percent asymptomatic days increased in all the groups, but was not significant. The additional drug requirement decreased significantly only in the group taking choline. All groups showed an improvement in SGaw at FRC and percent fall in specific airways conductance (SGaw) at RV, but non-significant. A significant fall in bronchial hyperreactivity (BHR) was observed in the group taking choline, which was not consistent, whereas a marginal increase in BHR in the control and DSCG groups was observed. It is concluded that choline, an anti-inflammatory agent which acts by lowering lipophosphatidyl choline (LPC), plays an active role in subjective as well as functional improvement in bronchial asthma. However, a dose related response is yet to be established.